In Massachusetts, researchers found a way to help prevent fibrosis, or scar tissue from developing around medical implant devices. While biomaterial devices have been increasingly replacing metal ones in order to offer a more natural, less rejected type of material for patients’ bodies, biomaterial implants still face fibrosis issues which can impact how well the implant works. But researchers now can fight back against the scar tissue issue by blocking the molecule, CSF1, which signals to macrophages in the body to start building the scar tissue. Once blocked, the body doesn’t create the scar tissue, but interestingly, still allows the body to heal wounds and carry out other important functions. While they tested it on three different biomaterials, researchers believe it will work on any biomaterial and devices such as pacemakers and glucose sensors for diabetes patients.
Latest article
Ajinomoto combines two biotech ingredients in futuristic latte
In Singapore, iced lattes made from beanless coffee and cow-free proteins pulled from air will be available shortly in a preview at the country’s...
San Fran hotspot Fiorella hosts Mission Barns’ first cultivated pork sale
In California, cultivated meat maker Mission Barns has sold its pork for the first time at an exclusive dinner at San Francisco hot spot...
Uluu raises $10.4M to scale seaweed-based plastic
In Australia, seaweed-based plastic startup Uluu has raised AU$16 million (US$10.4 million) to build a demonstration plant to prove the viability of its technology.
Uluu’s...